Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2026-02-01 @ 12:16 PM
Study NCT ID:
NCT01214668
Status:
COMPLETED
Last Update Posted:
2019-01-04
First Post:
2010-10-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-Escalation Study of LY573636-sodium and Liposomal Doxorubicin in Patients With Advanced Solid Tumors
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumors | View |
Keywords: